Group 1 - The core issue revolves around the controversy regarding Han Shu's face masks containing the banned ingredient Epidermal Growth Factor (EGF), leading to a significant trust crisis for the brand and its parent company, Up Beauty Co. [2][3] - Han Shu's response included presenting testing reports claiming no EGF was added, but discrepancies in test results from different third-party organizations raise questions about the legitimacy of the findings [4][9] - The investigation highlighted that the cosmetic industry may have "AB formula" practices, where different formulations are used for testing and actual production, contributing to the confusion [4][10] Group 2 - The pricing strategy of Han Shu has come under scrutiny, with reports indicating that a product priced at 399 yuan may only cost around 26 yuan to produce, raising concerns about inflated pricing and marketing over substance [10][12] - Han Shu's heavy reliance on marketing, with significant sales expenses amounting to 23.37 billion yuan in the first half of 2025, contrasts sharply with its low research and development expenditure of only 1.03 billion yuan [11][12] - Up Beauty Co. is heavily dependent on Han Shu, which accounted for 81.4% of the company's total revenue in the first half of 2025, indicating a lack of diversification in its brand portfolio [12][13] Group 3 - The company has attempted to revitalize its other brands, such as One Leaf, but faces challenges due to market saturation and lack of unique competitive advantages [13][14] - The ongoing controversy and reliance on a single brand may hinder Up Beauty Co.'s long-term stability and growth, especially in a highly competitive beauty market [14]
央视曝光韩束涉嫌违法添加，上美股份创始人吕义雄的百亿目标遇阻